相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis
Susanne Gaul et al.
JOURNAL OF HEPATOLOGY (2021)
Immunological mechanisms and therapeutic targets of fatty liver diseases
Hua Wang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis
Gai Gao et al.
JOURNAL OF NATURAL MEDICINES (2021)
Malvidin-3-O-Glucoside from Blueberry Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Transcription Factor EB-Mediated Lysosomal Function and Activating the Nrf2/ARE Signaling Pathway
Yang Xu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)
Attenuating Effects of Dieckol on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Decreasing the NLRP3 Inflammasome and Pyroptosis
Seyeon Oh et al.
MARINE DRUGS (2021)
Anti-oxidative effects of superoxide dismutase 3 on inflammatory diseases
Nguyen Hoai Nguyen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
Structural Mechanism for GSDMD Targeting by Autoprocessed Caspases in Pyroptosis
Kun Wang et al.
CELL (2020)
TRPM2, linking oxidative stress and Ca2+ permeation to NLRP3 inflammasome activation
Longfei Wang et al.
CURRENT OPINION IN IMMUNOLOGY (2020)
Cardioprotective effect of the polysaccharide from Ophiopogon japonicus on isoproterenol-induced myocardial ischemia in rats
Sairong Fan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover
Jorge Simon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration
Macarena Ortiz et al.
DIGESTIVE AND LIVER DISEASE (2020)
Non-alcoholic fatty liver disease
Wenhao Li et al.
CLINICAL MEDICINE (2020)
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
Nathan Kelley et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases
Na An et al.
FRONTIERS IN IMMUNOLOGY (2019)
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis
Jie Li et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease
Jin Lee et al.
ARCHIVES OF PHARMACAL RESEARCH (2019)
Docosahexaenoic acid and hydroxytyrosol co-administration fully prevents liver steatosis and related parameters in mice subjected to high-fat diet: A molecular approach
Sandra A. Soto-Alarcon et al.
BIOFACTORS (2019)
Role of NLRP3 inflammasome in inflammatory bowel diseases
Evanthia Tourkochristou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Inhibition of TREM1 reduces inflammation and oxidative stress after spinal cord injury (SCI) associated with HO-1 expressions
Zhenhuan Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Pyroptosis: An inflammatory link between NAFLD and NASH with potential therapeutic implications
Juliane I. Beier et al.
JOURNAL OF HEPATOLOGY (2018)
Apigenin prevents metabolic syndrome in high-fructose diet-fed mice by Keap1-Nrf2 pathway
Min Yang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice
Bing Xu et al.
JOURNAL OF HEPATOLOGY (2018)
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes et al.
JOURNAL OF HEPATOLOGY (2018)
Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin
Yuji Ogawa et al.
SCIENTIFIC REPORTS (2018)
A systematic review of the present and future of non-alcoholic fatty liver disease
Christiana Lucas et al.
CLINICAL AND EXPERIMENTAL HEPATOLOGY (2018)
ERK-dependent mTOR pathway is involved in berberine-induced autophagy in hepatic steatosis (vol 57, pg 251, 2016)
Qin He et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2017)
Chronic administration of saturated fats and fructose differently affect SREBP activity resulting in different modulation of Nrf2 and Nlrp3 inflammasome pathways in mice liver
Debora Nigro et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2017)
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
Brandon J. Perumpail et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Nuclear Factor E2-Related Factor-2 Negatively Regulates NLRP3 Inflammasome Activity by Inhibiting Reactive Oxygen Species-Induced NLRP3 Priming
Xiuting Liu et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Benzyl alcohol allergy mimicking corticosteroid allergy
Minna E. Kubin et al.
CONTACT DERMATITIS (2016)
Pathogenesis of Nonalcoholic Steatohepatitis
Mariana Verdelho Machado et al.
GASTROENTEROLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats
Chunchun Ding et al.
SCIENTIFIC REPORTS (2016)
Coronary Endothelial Dysfunction Induced by Nucleotide Oligomerization Domain-Like Receptor Protein with Pyrin Domain Containing 3 Inflammasome Activation During Hypercholesterolemia: Beyond Inflammation
Yang Zhang et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Jianjin Shi et al.
NATURE (2015)
Inflammasome activation and function in liver disease
Gyongyi Szabo et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease
Wenjing Zeng et al.
SCIENTIFIC REPORTS (2015)
Biomarkers of liver cell death
Akiko Eguchi et al.
JOURNAL OF HEPATOLOGY (2014)
IL-1 Signaling in Obesity-Induced Hepatic Lipogenesis and Steatosis
Kimberly A. Negrin et al.
PLOS ONE (2014)
Non-alcoholic fatty liver disease and cardiovascular risk
Angel Brea et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)
Akinobu Takaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Activation and regulation of the inflammasomes
Eicke Latz et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Nrf2: A Potential Target for New Therapeutics in Liver Disease
A. M. Bataille et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-Imidazolide
Soona Shin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
A key role for redox signaling in rapid P2X7 receptor-induced IL-1β processing in human monocytes
James Hewinson et al.
JOURNAL OF IMMUNOLOGY (2008)
Arachidonic acid promotes glutamate-induced cell death associated with necrosis by 12-lipoxygenase activation in glioma cells
Yoshihiro Higuchi et al.
LIFE SCIENCES (2007)
Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease
Lauren M. Aleksunes et al.
TOXICOLOGIC PATHOLOGY (2007)
Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis
K Iida et al.
CANCER RESEARCH (2004)
分享论文
